In late 2007 caprotec™ bioanalytics GmbH received a total of €6 million ($8.8 million) financing from Creathor Venture, IBB Beteiligungsgesellschaft (VC Fond Berlin), KfW (ERP Startfonds) as well as Prof. Dr. Schulte, co-founder of EVOTEC AG and several other business angels.

If you are a member of the investment community and would like to learn more about caprotec, contact us: or register to receive headline stories every time a news release is issued by using our contact form.

 

About IBB Beteiligungsgesellschaft

IBB Beteiligungsgesellschaft (www.ibb-bet.de) provides equity financing to innovative Berlin-based companies. The firm is the regional market leader in venture capital in Berlin. IBB Beteiligungsgesellschaft was founded in 1997 as a fully owned subsidiary of Investitionsbank Berlin (IBB). The funds provided are to be used for the development and launch of innovative products and services or creative business concepts. IBB Beteiligungsgesellschaft manages the „VC Fonds Technologie Berlin“ fund (€ 52m) and the „VC Fonds Kreativwirtschaft Berlin“ fund (€ 30m). Both funds were started as joint initiatives of IBB and the State of Berlin. They are co-financed by the European Regional Development Fund (ERDF). Set up in 2008, VC Fonds Kreativwirtschaft Berlin is the first german venture capital fund solely aimed at companies from the creative industries. The track record of IBB Beteiligungsgesellschaft includes successful IPOs and a large number of trade sales to strategic partners.

Contact:
IBB Beteiligungsgesellschaft mbH
Bundesallee 171
10715 Berlin
Tel.: +49 30 21 25 32 01
Fax: +49 30 21 25 32 02
Email: venture@ibb-bet.de
Internet: www.ibb-bet.de

 

About Creathor Venture

Creathor Venture invests in technology-oriented companies and entrepreneurs from the fields of life science, IT, telecommunication, new media, new materials, electronics, nanotechnology and clean tech. Creathor Venture's management team includes Dr. Gert Köhler, the founder of the former Technologieholding VC GmbH, as well as Ingo Franz and Karlheinz Schmelig. The team has been working in early-stage venture capital for 20 years. During that time more than 200 technology companies have been financed and over 20 IPOs as well as numerous trade sales have been conducted. Extraordinarily successful companies that the partners have managed from the first round of financing to IPO include Micronas (TechDax, SMI), SEZ (SMI), Intershop (Prime Segment),Infovista (NASDAQ, Nouveau Marché) and ITN Nanovation (Prime Segment).

Contact:
Karlheinz Schmelig
Creathor Venture Management GmbH
Marienbader Platz 1
61348 Bad Homburg
Germany
Tel.: +49 6172 13 97 20
Email: creathor@creathor.de
Internet: www.creathor.de

 

About KfW Mittelstandsbank

KfW Mittelstandsbank brings together all KfW's offers for business start-ups and small and medium-sized enterprises, thus promoting commercial investments over the entire life cycle of an enterprise. The SME financing products are structured according to the three pillars of loan, mezzanine and equity capital. In addition to investment finance, KfW Mittelstandsbank provides relevant information and advice. In promoting investment by German companies in Germany and abroad, KfW Mittelstandsbank acts as a bank behind credit institutions and other financial intermediaries, working with them as partners. KfW Mittelstandsbank is continuously developing its promotional instruments and adjusting them to changes in the market.

Contact:
KfW Bankengruppe
Niederlassung Berlin
Charlottenstr. 33/33a
10117 Berlin
Infocenter:
Tel.: 01801 24 11 24
E-Mail: infocenter@kfw-mittelstandsbank.de
Internet: www.kfw-mittelstandsbank.de

 

About LBBW Venture Capital GmbH

LBBW Venture is a subsidiary of Landesbank Baden-Württemberg and invests in Life Science, IT and industrial technology in Germany since more than ten years. Portfolio companies in the Life Science sector are Cellzome, Curacyte Pharmaceuticals, Phenex Pharmaceuticals, mtm laboratories and several fund in fund investments. Most recently the portfolio companies ProbioGen and Sloning were successfully sold.

Contact:
LBBW Venture Capital GmbH
Dr. Harald Poth
Königstr. 10c
70173 Stuttgart
Germany
Tel.: +49 711 305 89 20 61
Fax: +49 711 305 89 20 99
E-Mail: harald.poth@LBBW-venture.de